Clari Vest Asset Management LLC Cue Biopharma, Inc. Transaction History

Clari Vest Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 09, 2021	SELL	$10.9 - $14.53 $438,180 - $584,106	-40,200 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$11.2 - $16.09 $146,720 - $210,779	13,100 Added 48.34%	40,200 $490,000
Q4 2020 Feb 09, 2021	BUY	$11.12 - $16.4 $93,408 - $137,760	8,400 Added 44.92%	27,100 $339,000
Q3 2020 Nov 09, 2020	BUY	$15.05 - $23.54 $31,605 - $49,434	2,100 Added 12.65%	18,700 $282,000
Q2 2020 Aug 12, 2020	BUY	$12.7 - $30.73 $210,820 - $510,118	16,600 New	16,600 $407,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.